66 related articles for article (PubMed ID: 2561433)
1. [Measurement of angiotensin I convertase activity in the serum of the rat].
Dudkiewicz J; Suska T; Tautt J
Acta Pol Pharm; 1989; 46(4):391-5. PubMed ID: 2561433
[TBL] [Abstract][Full Text] [Related]
2. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
[TBL] [Abstract][Full Text] [Related]
3. Effect of physostigmine on plasma angiotensin converting enzyme activity in rat.
Verma PS; Taylor RE
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):245-8. PubMed ID: 2177564
[TBL] [Abstract][Full Text] [Related]
4. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
Vernigora AN; Nikishin NN; Gengin MT
Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin converting enzyme activity in the blood and lung tissue of spontaneously hypertensive rats].
Komissarova NV; Gomazkov OA; Karpitskiĭ VV
Biull Eksp Biol Med; 1983 Dec; 96(12):30-2. PubMed ID: 6318853
[TBL] [Abstract][Full Text] [Related]
6. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
7. An improved fluorometric assay of rat serum and plasma converting enzyme.
Santos RA; Krieger EM; Greene LJ
Hypertension; 1985; 7(2):244-52. PubMed ID: 2984118
[TBL] [Abstract][Full Text] [Related]
8. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test].
Vernigora AN; Gengin MT; Nikishin NN; Shchetinina NV
Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656
[TBL] [Abstract][Full Text] [Related]
9. [Angiotensin converting enzyme activity in the serum of animals after a single intraperitoneal administration of cadmium in various concentrations].
Beslagić R
Med Arh; 1988; 42(5-6):249-51. PubMed ID: 2855940
[No Abstract] [Full Text] [Related]
10. Modulation of angiotensin-converting enzyme by nitric oxide.
Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C
Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545
[TBL] [Abstract][Full Text] [Related]
11. Effects of E. coli endotoxin on rat plasma angiotensin converting enzyme activity in vitro and in vivo.
Deitz DM; Swartz KR; Wright M; Murphy E; Connell RS; Harrison MW
Circ Shock; 1987; 21(1):23-9. PubMed ID: 3028670
[TBL] [Abstract][Full Text] [Related]
12. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
13. [Serum angiotensin-converting enzyme activity in disorders of thyroid gland function--clinical and experimental findings].
Filipović N; Hanjalić J; Zubović I; Borcić N; Huskić J
Srp Arh Celok Lek; 1985 Aug; 113(8):665-71. PubMed ID: 3003935
[No Abstract] [Full Text] [Related]
14. [Angiotensin I converting enzyme and carboxypeptidase B-like enzymes in sarcoidosis and other lung diseases].
Schweisfurth H; Heinrich J; Brugger E; Wernze H; Wichmann J; Ertl G
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():562-4. PubMed ID: 6316314
[No Abstract] [Full Text] [Related]
15. [Modification of the Friedland-Silverstein technic for the determination of the activity of angiotensin I converting enzyme].
Harrabi S; Revol A; Biot N; Perrin-Fayolle M
Ann Biol Clin (Paris); 1984; 42(2):123-8. PubMed ID: 6089616
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of kininases.
Erdös EG
Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
[No Abstract] [Full Text] [Related]
17. [Determination of angiotensin-converting enzyme activity in internal diseases].
Danev S; Nashkov A; Dobrev S; Kovacheva S
Vutr Boles; 1988; 27(4):86-8. PubMed ID: 2850657
[TBL] [Abstract][Full Text] [Related]
18. [Determination of carboxycathepsin (peptidyl dipeptidase) activity in human blood serum].
Pavlikhina LV; Eliseeva IuE; Pozdnev VF; Orekhovich VN
Vopr Med Khim; 1975; 21(1):54-60. PubMed ID: 164083
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin-converting enzyme activity in dehydrated rats].
Huskić J; Plazanić D; Huskić G; Ostojić Lj; Martinović S
Srp Arh Celok Lek; 1992; 120(11-12):321-3. PubMed ID: 1340641
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
